Synthesis and X-ray crystal structure analysis of 4-(3,4-dichlorophenyl)-2-(3,4,5-trimethoxy-benzylidene)-3,4-dihydr o -naphthalen-1(2H)-one: Sertraline key intermediate analog
The novel bioactive compound 4-(3,4-dichlorophenyl)-2-(3,4,5-trimethoxy-benzylidene)-3,4-dihydr o -naphthalen-1(2H)-one was synthesised in three different methods, namely, conventional, MW irradiation with solvent and MW irradiation without solvent. The synthesised compound was characterised by spec...
Saved in:
Published in | Journal of chemical research Vol. 2006; no. 11; pp. 730 - 732 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
01.11.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The novel bioactive compound 4-(3,4-dichlorophenyl)-2-(3,4,5-trimethoxy-benzylidene)-3,4-dihydr o -naphthalen-1(2H)-one was synthesised in three different methods, namely, conventional, MW irradiation with solvent and MW irradiation without solvent. The synthesised compound was characterised by spectroscopic techniques and finally confirmed by X-ray crystal structure analysis. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Feature-1 |
ISSN: | 1747-5198 2047-6507 |
DOI: | 10.3184/030823406779173271 |